Brendan Bertsch

Brendan Bertsch is an experienced executive in strategic pricing and market access, currently serving as the Head of Strategic Pricing at Genmab since November 2021, where responsibilities include developing and implementing pricing and contracting strategies. Prior to this role, Brendan held significant positions at Mesoblast Limited as Vice President of Market Access & Pricing/Trade & Distribution, and at Boehringer Ingelheim as Executive Director of Strategic Pricing & Contract Operations. Brendan's early career included leadership roles at Optimer Pharmaceuticals and Pfizer Pharmaceuticals, focusing on pricing, contracts, and government strategy. Brendan's background is supported by an MBA from Columbia Business School and a BS in Finance/Management Information Systems from the University at Albany.